# FDA Inspection 1097061 - Ajanta Pharma Ltd. - June 28, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/ajanta-pharma-ltd/dcc8e789-9501-4bd0-9137-a7594d3fd15c
Source feed: FDA_Inspections

> FDA Inspection 1097061 for Ajanta Pharma Ltd. on June 28, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1097061
- Company Name: Ajanta Pharma Ltd.
- Inspection Date: 2019-06-28
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1235564 - 2024-03-05](https://www.globalkeysolutions.net/records/fda_inspections/ajanta-pharma-ltd/569ea093-1787-4fef-a865-1ddc3c6fa809)
- [FDA Inspection 1009806 - 2017-02-07](https://www.globalkeysolutions.net/records/fda_inspections/ajanta-pharma-ltd/37667b7f-e3eb-484d-b81a-6f18f5d14860)
- [FDA Inspection 917795 - 2015-03-20](https://www.globalkeysolutions.net/records/fda_inspections/ajanta-pharma-ltd/5b1d556e-3f3c-4e3a-a01b-3694f397eeea)
- [FDA Inspection 801522 - 2012-09-06](https://www.globalkeysolutions.net/records/fda_inspections/ajanta-pharma-ltd/2feba6a5-e7b1-4e8e-843c-3cf9535a1b11)

Company: https://www.globalkeysolutions.net/companies/ajanta-pharma-ltd/040efb87-46b2-4747-b87d-c1d87daad1e7

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c